Menlo Park, CA, United States of America

Eugene Yuji Tanimoto


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Eugene Yuji Tanimoto

Introduction

Eugene Yuji Tanimoto is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of molecular biology and diagnostics. With a focus on enhancing detection methods, Tanimoto has been awarded 2 patents for his innovative approaches.

Latest Patents

Tanimoto's latest patents include methods and compositions for amplifying detectable signals in specific binding assays. These methods provide a means for detecting target molecules in a sample, particularly nucleic acid targets. The process involves hybridizing a nucleic acid target to a nucleic acid probe, where the target includes a binding ligand. The hybridized target is then contacted with a receptor that has multiple binding sites for the ligand. This receptor is further contacted with an amplification reagent, which enhances the detectable signal. The presence of the complexed amplification reagent can be detected through various means, such as fluorescent labels. This innovative approach allows for the screening and detection of a large number of nucleic acids, significantly improving the efficiency of specific binding assays.

Career Highlights

Eugene Yuji Tanimoto is currently associated with Affymetrix, Inc., a company known for its advancements in genetic analysis and molecular diagnostics. His work has contributed to the development of more effective diagnostic tools, which are crucial in various scientific and medical applications.

Collaborations

Some of Tanimoto's notable coworkers include Martin J Goldberg and Govinda Rao S Yelagalawadi. Their collaborative efforts have furthered the research and development of innovative technologies in the field.

Conclusion

Eugene Yuji Tanimoto's contributions to the field of molecular biology through his patents and work at Affymetrix, Inc. highlight his role as a significant innovator. His methods for amplifying detectable signals in specific binding assays represent a valuable advancement in the detection of target molecules.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…